4556 — Kainos Laboratories Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro CapContrarian
- ¥4bn
- ¥2bn
- ¥5bn
- 88
- 86
- 26
- 79
Annual income statement for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,671 | 4,609 | 4,258 | 4,615 | 4,923 |
| Cost of Revenue | |||||
| Gross Profit | 2,278 | 2,379 | 2,311 | 2,407 | 2,513 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,091 | 4,013 | 3,667 | 3,873 | 4,111 |
| Operating Profit | 579 | 596 | 591 | 742 | 812 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 590 | 599 | 613 | 767 | 845 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 386 | 399 | 417 | 512 | 568 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 386 | 399 | 417 | 512 | 568 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 386 | 399 | 417 | 512 | 568 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 99.8 | 99.9 | 107 | 128 | 138 |
| Dividends per Share |